Evaluation of A Novel Risk Factor Screening Tool for Gestational Diabetes Mellitus: A Machine Learning Based Predictive Method

Authors

  • Usha Adiga Department of Biochemistry, Apollo Institute of Medical Sciences and Research Chittoor, Murukambattu - 517127, Chittoor, Andhra Pradesh, India
  • Tirthal Rai Department of Biochemistry, A.J. Institute of Medical Sciences and Research Centre, Mangalore - 575004, Karnataka, India
  • Sampara Vasishta Department of Biochemistry, Apollo Institute of Medical Sciences and Research Chittoor, Murukambattu - 517127, Chittoor, Andhra Pradesh, India
  • Banubadi Anil Kishore Department of Biochemistry, Apollo Institute of Medical Sciences and Research Chittoor, Murukambattu - 517127, Chittoor, Andhra Pradesh, India
  • Tunuguntla Amulya Department of Biochemistry, Apollo Institute of Medical Sciences and Research Chittoor, Murukambattu - 517127, Chittoor, Andhra Pradesh, India
  • Lokesh Ravi Centre for Digital Health and Precision Medicine, The Apollo University, Chittoor, Andhra Pradesh, 517127, India

DOI:

https://doi.org/10.6000/1929-6029.2025.14.55

Keywords:

Artificial Intelligence, ROC, Naïve Bayes, XG Boost

Abstract

Introduction: Gestational diabetes mellitus (GDM) is a significant pregnancy complication linked to adverse outcomes for both mother and child. Early identification of high-risk individuals is crucial for effective management and prevention for the onset/progression of the GDM. Our study aims to a) evaluate the effectiveness of a newly developed machine learning based risk factor screening tool for predicting GDM and b) to compare its predictive performance against established models and current literature.

Methods: This study explored SNP data from the leptin (LEP) and leptin receptor (LEPR) genes to develop machine learning models for predicting gestational diabetes mellitus (GDM). It included data preprocessing, such as cleaning and feature selection, focusing on genetic markers, metabolic parameters, and demographic information. Various algorithms, including Logistic Regression, Decision Trees, and Random Forests, were used, and their performance was evaluated using metrics like accuracy and ROC-AUC to determine the best model for GDM prediction.

Results: The newly developed screening tool demonstrated a sensitivity of 85%, specificity of 78%, positive predictive value (PPV) of 68%, and negative predictive value (NPV) of 90% in predicting GDM. Comparatively, machine learning models showed higher sensitivity (90-95%) but lower specificity (65-75%).

Conclusion: The developed risk factor screening tool is a viable method for predicting GDM, with accuracy metrics comparable to advanced machine learning models and established literature. Future research should focus on refining these tools and exploring their integration into routine prenatal care to enhance early detection and intervention strategies for GDM.

References

American Diabetes Association. 14. Management of diabetes in pregnancy: standards of medical care in diabetes—2021. Diabetes Care 2020; 44(Suppl 1): S200-S210. DOI: https://doi.org/10.2337/dc21-S014

Wang H, et al. IDF Diabetes Atlas: estimation of global and regional gestational diabetes mellitus prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group’s criteria. Diabetes Res Clin Pract 2022; 183: 109050. DOI: https://doi.org/10.1016/j.diabres.2021.109050

Yoon KH, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006; 368(9548): 1681-1688. DOI: https://doi.org/10.1016/S0140-6736(06)69703-1

Nguyen CL, Pham NM, Binns CW, Van Duong D, Lee AH. Prevalence of gestational diabetes mellitus in Eastern and Southeastern Asia: a systematic review and meta-analysis. J Diabetes Res 2018; 2018: 6536974. DOI: https://doi.org/10.1155/2018/6536974

Bimson BE, Rosenn BM, Morris SA, Sasso EB, Schwartz RA, Brustman LE. Current trends in the diagnosis and management of gestational diabetes mellitus in the United States. J Matern Neonatal Med 2017; 30(21): 2607-2612. DOI: https://doi.org/10.1080/14767058.2016.1257603

Gallardo-Rincón H, et al. Diagnostic accuracy of capillary blood glucometer testing for gestational diabetes. Diabetes Metab Syndr Obes 2022; 15: 3855-3870. DOI: https://doi.org/10.2147/DMSO.S389420

Adiga U, Banawalikar N, Rai T. Association of leptin and leptin receptor gene polymorphisms with insulin resistance in pregnant women: a cross-sectional study. F1000Research 2022; 11: 692. DOI: https://doi.org/10.12688/f1000research.122537.1

Rustam F, et al. Enhanced detection of diabetes mellitus using novel ensemble feature engineering approach and machine learning model. Sci Rep 2024; 14(1): 23274. DOI: https://doi.org/10.1038/s41598-024-74357-w

Lu HY, et al. Digital health and machine learning technologies for blood glucose monitoring and management of gestational diabetes. IEEE Rev Biomed Eng 2024; 17: 98-117. DOI: https://doi.org/10.1109/RBME.2023.3242261

Kurt B, et al. Prediction of gestational diabetes using deep learning and Bayesian optimization and traditional machine learning techniques. Med Biol Eng Comput 2023; 61(7): 1649-1660. DOI: https://doi.org/10.1007/s11517-023-02800-7

Watanabe M, et al. Prediction of gestational diabetes mellitus using machine learning from birth cohort data of the Japan Environment and Children’s Study. Sci Rep 2023; 13(1): 17419. DOI: https://doi.org/10.2139/ssrn.4345460

Lachmann EH, Fox RA, Dennison RA, Usher-Smith JA, Meek CL, Aiken CE. Barriers to completing oral glucose tolerance testing in women at risk of gestational diabetes. Diabet Med 2020; 37(9): 1482-1489. DOI: https://doi.org/10.1111/dme.14292

Bogdanet D, O’Shea P, Lyons C, Shafat A, Dunne F. The oral glucose tolerance test—Is it time for a change?—A literature review with an emphasis on pregnancy. J Clin Med 2020; 9(11): 3451. DOI: https://doi.org/10.3390/jcm9113451

Kuo FY, Cheng K-C, Li Y, Cheng J-T. Oral glucose tolerance test in diabetes, the old method revisited. World J Diabetes 2021; 12(6): 786-793. DOI: https://doi.org/10.4239/wjd.v12.i6.786

Inthavong S, Jatavan P, Tongsong T. Predictive utility of biochemical markers for the diagnosis and prognosis of gestational diabetes mellitus. Int J Mol Sci 2024; 25(21): 11666. DOI: https://doi.org/10.3390/ijms252111666

Omazić J, et al. Early markers of gestational diabetes mellitus: what we know and which way forward? Biochem Med (Zagreb) 2021; 31(3): 30502. DOI: https://doi.org/10.11613/BM.2021.030502

Ruchat S-M, Vohl M-C, Weisnagel SJ, Rankinen T, Bouchard C, Pérusse L. Combining genetic markers and clinical risk factors improves the risk assessment of impaired glucose metabolism. Ann Med 2010; 42(3): 196-206. DOI: https://doi.org/10.3109/07853890903559716

Hosseini E, Mokhtari Z, Salehi Abargouei A, Mishra GD, Amani R. Maternal circulating leptin, tumor necrosis factor-alpha, and interleukine-6 in association with gestational diabetes mellitus: a systematic review and meta-analysis. Gynecol Endocrinol 2023; 39(1): 2183049. DOI: https://doi.org/10.1080/09513590.2023.2183049

Ramos-Levi A, et al. Genetic variants for prediction of gestational diabetes mellitus and modulation of susceptibility by a nutritional intervention based on a Mediterranean diet. Front Endocrinol (Lausanne) 2022; 13: 1036088. DOI: https://doi.org/10.3389/fendo.2022.1036088

Lappas M, Jinks D, Ugoni A, Louizos CCJ, Permezel M, Georgiou HM. Post-partum plasma C-peptide and ghrelin concentrations are predictive of type 2 diabetes in women with previous gestational diabetes mellitus. J Diabetes 2015; 7(4): 506-511. DOI: https://doi.org/10.1111/1753-0407.12209

Bianconi I, Aschbacher R, Pagani E. Current uses and future perspectives of genomic technologies in clinical microbiology. Antibiotics (Basel) 2023; 12(11): 1580. DOI: https://doi.org/10.3390/antibiotics12111580

Nafea AM, et al. Application of next-generation sequencing to identify different pathogens. Front Microbiol 2023; 14: 1329330. DOI: https://doi.org/10.3389/fmicb.2023.1329330

Tian Y, Li P. Genetic risk score to improve prediction and treatment in gestational diabetes mellitus. Front Endocrinol (Lausanne) 2022; 13: 955821. DOI: https://doi.org/10.3389/fendo.2022.955821

Zhang C, et al. Genetic variants and the risk of gestational diabetes mellitus: a systematic review. Hum Reprod Update 2013; 19(4): 376-390. DOI: https://doi.org/10.1093/humupd/dmt013

Wu Q, et al. An early prediction model for gestational diabetes mellitus based on genetic variants and clinical characteristics in China. Diabetol Metab Syndr 2022; 14(1): 15. DOI: https://doi.org/10.1186/s13098-022-00788-y

Kaya Y, Bütün Z, Çelik Ö, Salik EA, Tahta T, Yavuz AA. The early prediction of gestational diabetes mellitus by machine learning models. BMC Pregnancy Childbirth 2024; 24(1): 574. DOI: https://doi.org/10.1186/s12884-024-06783-7

Downloads

Published

2025-09-26

How to Cite

Adiga, U. ., Rai, T. ., Vasishta, S. ., Kishore, B. A. ., Amulya, T. ., & Ravi, L. . (2025). Evaluation of A Novel Risk Factor Screening Tool for Gestational Diabetes Mellitus: A Machine Learning Based Predictive Method. International Journal of Statistics in Medical Research, 14, 578–589. https://doi.org/10.6000/1929-6029.2025.14.55

Issue

Section

Special Issue: Trends in Artificial Intelligence and Machine Learning in Healthcare

Most read articles by the same author(s)